<DOC>
	<DOCNO>NCT02937766</DOCNO>
	<brief_summary>To demonstrate Makena® ( Hydroxyprogesterone Caproate Injection , 250 mg/mL ) deliver subcutaneously via auto-injector associate less pain compare intramuscular injection Makena®</brief_summary>
	<brief_title>Study Assessing Injection Pain Makena® ( Hydroxyprogesterone Caproate Injection , 250 mg/mL ) When Administered Via Subcutaneous Auto-injector v Intramuscular Injection Via Needle Syringe Healthy Post-menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>17-alpha-hydroxy-progesterone caproate</mesh_term>
	<mesh_term>11-hydroxyprogesterone</mesh_term>
	<criteria>1 . Female subject age 50 75 year age , inclusive , Screening Visit . 2 . FSH level great 40 mIU/mL . 3 . Naturally surgically postmenopausal without intact uterus . 1 . Have history positive test result HIV hepatitis B C. 2 . A significant history current evidence chronic infectious disease , organ dysfunction especially cardiovascular , renal , hepatic disorder medical condition . 3 . Receiving receive chronic opioid therapy within 12 month . 4 . Unwilling stop taking/using : pain medication . topical analgesic antiinflammatory treatment . Topical analgesic must wash least 72 hour area treat randomization . 5 . History alcohol abuse ( regularly drink &gt; 4 unit alcohol per day ; 8 oz . beer , 3 oz . wine , 1 oz . spirit ) prescription/illicit drug abuse last 12 month . 6 . Currently take estrogen/progesterone hormone replacement therapy ( HRT ) . 7 . History allergy sensitivity hydroxyprogesterone caproate , castor oil constituent study medication history drug hypersensitivity intolerance . 8 . Poorly control diabetes ( Hgb A1C &gt; 8 ) . 9 . Current history thrombosis thromboembolic disorder . 10 . Known suspected breast cancer , hormonesensitive cancer tumor , history condition within last 5 year . 11 . Any current recent ( within previous 12 month ) vaginal bleeding . 12 . Uncontrolled hypertension . 13 . A chronic pain condition ( i.e . chronic back pain ) may confound assessment injection pain .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>